ABSTRACT Background/Aims: Insulin resistance (IR) is closely linked with chronic hepatitis C virus (HCV) and its complications
INTRODUCTION
Hepatitis C virus (HCV) infection is a major health problem worldwide with considerable morbidity and mortality (1) . One of the main mechanisms responsible for HCV complications is insulin resistance (IR), as the virus per se is thought to decrease the sensitivity of insulin receptors (2, 3) . Several studies have linked HCV-induced IR with more hepatic inflammation and fibrosis (4,5). Accordingly, as long as hepatic fibrosis correlates with the development of esophageal varices (EV), IR is thought to be associated with the occurrence of the latter (6) . On the other hand, endoscopic screening of all patients with cirrhosis for any variceal evidence has been recommended (7).
However, patients with early stages of cirrhosis often display much discomfort with such invasive procedures. Therefore, the poor compliance of those "asymptomatic" individuals has challenged the researchers to identify several predictors of variceal development with a view to reducing the need for diagnostic endoscopy (8,9).
In the context of IR, Camma et al. (10) identified the homeostatic model assessment for insulin resistance (HOMA-IR) score as a predictor of EV. The study was conducted on patients with Child A cirrhosis with HCV etiology. Further, it included comorbid subjects with obesity and/or diabetes mellitus. Nevertheless, even in patients with chronic HCV who are not obese or having diabetes, IR is well acknowledged to aggravate fibrosis (11) (12) (13) (14) . It is noteworthy, however, that the presence of obesity and/or diabetes is thought to adversely impress the course of liver cirrhosis (12,15). Furthermore, the state of IR is initiated in the early stages of chronic HCV, and its mechanisms are different from that of the more prevalent lifestyle-associated IR (3, [16] [17] [18] .
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Therefore, we hypothesized that HOMA-IR scoring could be valid as a predictor of EV for patients with compensated cirrhosis with underlying HCV etiology in the absence of diabetes and metabolic syndrome. This was the key objective of the current study.
MATERIALS AND METHODS
We recruited 100 patients without diabetes with well compensated (Child-Pugh A) HCV-induced cirrhosis who did not meet the criteria of metabolic syndrome. Patients were subjected to thorough history taking and complete physical examination, searching for manifestations of chronic liver disease and diabetes, with special stress on any previous antiviral administration with its results.
Diagnosis of cirrhosis was based on the clinical, biochemical, and ultrasonographic criteria (19) . The severity of the disease was assessed by the Child-Pugh score (1973) . Patients administering insulin-sensitizing drugs, alcohol, or β blocker or having advanced cirrhosis, portal vein thrombosis, or severe comorbid diseases were excluded from the study. Patients with coinfection with hepatitis B virus or meeting the diagnostic criteria of diabetes mellitus (fasting blood glucose ≥126 mg/dL, 2-hour postprandial ≥200 mg/dL, and/or patient was already under therapy) or metabolic syndrome were also excluded.
Metabolic syndrome was defined based on the National Cholesterol Education Program Adult Treatment Panel III as the presence of three or more of the following five criteria (or the patient was under therapy): waist circumference ≥40 in. (for men) or 35 in. (for women), blood pressure ≥130/85 mm Hg, fasting triglyceride level ≥150 mg/ dL, fasting high-density lipoprotein cholesterol (HDL-C) level <40 mg/dL (for men) or 50 mg/dL (for women), and fasting blood sugar ≥100 mg/dL (20) .
Laboratory investigations
After a 12-hour overnight fasting, a venous sample was extracted to determine the serum levels of insulin, alanine aminotransferase, aspartate aminotransferase, bilirubin, albumin, total cholesterol, HDL-C, triglycerides, and plasma glucose (using a fully automated chemistry analyzer, Beckman Coulter AU480), as well as prothrombin time and viral markers (HCV antibody (Ab) and hepatitis B virus surface antigen (HBsAg)). The 2-hour postprandial plasma glucose concentration was assessed by another appropriate sample.
Hepatitis C virus Ab was determined by immunofluorescence assay (bioMérieux SA, France), with HBsAg assayed by enzyme-linked immunosorbent assay (ELISA; Biomedica, Sorin, Italy). On the other hand, prothrombin time was measured by a coagulometer (Coatron M1, TECO, Neufahrn, Germany) using a reagent (DiaMed GmbH, Ottobrunn, Germany).
Serum insulin was measured by chemiluminescence (Immulite, Siemens, UK). Thereafter, IR was estimated by the HOMA equation: HOMA-IR=fasting insulin (μU/mL)×fast-ing glucose (mg/dL)/405 (21) .
Abdominal ultrasonography
All patients were examined using an ultrasound (Aplio™ 500 Platinum, Toshiba, Japan), searching for findings suggestive of cirrhosis, such as coarse heterogeneous echo pattern, surface nodularity, attenuated blood supply, and caudate lobe hypertrophy. Findings suggestive of portal hypertension were also reported. The bipolar diameter of the spleen, as well as diameters of the portal vein and the right liver lobe, was all measured.
Endoscopy
Upper gastrointestinal endoscopy was performed by the same endoscopist for all the included population using the PENTAX Medical EPK-i5000 video processor (PEN-TAX Medical, Japan). EV were detected and graded from 1 to 4 as classified by de Franchis et al. (22) .
Statistical analysis
Data were analyzed using the Statistical Package for Social Sciences version 22 (IBM Corp.; Armonk, NY, USA). Quantitative data were expressed as mean±standard deviation and analyzed by independent t-test or oneway analysis of variance (ANOVA) as appropriate. Qualitative data were expressed as number and analyzed by χ 2 test.
The correlation was made using a Pearson correlation test, and logistic regression was applied to evaluate the significant risk factors for EV. A p<0.05 was considered as statistically significant.
Receiver operating characteristic (ROC) curves were elaborated to determine the best cut-off values and to identify the area under the ROC curve (AUC) of the independent variables associated with the presence of EV. The specificity and sensitivity of the significant predictors were compared.
Ethical approval
The study was approved by the local research and ethics committee of the Al-Azhar University School of Medicine and performed in accordance with the principles of the Declaration of Helsinki and its appendices. Informed consent was obtained from the participants with a full explanation of the study protocol. Throughout the univariate comparison of variables, we found no significant association between the classic liver function tests and the occurrence of EV. On the contrary, we recorded a significant increase in serum insulin, fasting plasma glucose (though not in the diabetic range), HOMA-IR score, and bipolar diameter of the spleen, with a significant decrease in HDL-C levels and platelet counts in patients with EV than the others (Table 2) .
After exclusion of serum insulin and fasting glucose to avoid multicollinearity, multivariate logistic regression analysis of the above significant variables revealed high HOMA-IR score to be the only independent predictor of the existence of varices (odds ratio (OR), 1.303; 95% confidence interval (95% CI), 1.014-1.6741; p=0.039) ( Table 3 , test 1).
The statistically significant "paradoxical" alteration of both insulin and HDL-C values between patients with and without varices and within the variceal grades (Table 2, Figure  1 ) has inspired us to test a ratio between them as another predictor of variceal existence. Therefore, we applied the Moreover, the ROC curve performed to compare those independent predictors revealed an insulin/HDL-C ratio Furthermore, by applying the Pearson correlation test for studying the direct relationship between both independent predictors, we noticed a strong positive correlation (r=0.867, p<0.001) (Figure 3 ). On the contrary, on comparing the grades of EV in terms of either HOMA-IR score or insulin/HDL-C ratio separately, one-way ANOVA provided significant associations for both (p<0.001 and p=0.007, respectively) ( Figure  4 , 5).
Particularly, a cohort of 27 patients among our study population had already received specific anti-HCV therapy in the form of the sofosbuvir-daclatasvir regimen. They all had a sustained virologic response, with documented HCV-RNA below the detection limit after at least 6 months of stopping the treatment. It is noteworthy that the statistical application of the above two independent predictors in that group revealed no significant associations with the presence of varices (Table 4 , tests 3, 4).
DISCUSSION
Insulin resistance is relatively an early phenomenon during the course of HCV infection that plays a significant role in the pathogenesis of hepatic fibrosis (3-5,11,16-18). Consequently, it may be linked with the development of EV (10).
In contrast, it is well acknowledged that HCV infection is also associated with type 2 diabetes mellitus, in which hyperglycemia is another additional risk for more hepatic fibrosis (18) . Moreover, the role of obesity per se in perturbing the course of compensated cirrhosis has been recognized (11, 15) .
To the best of our knowledge, this is the first study to evaluate HOMA-IR score as a predictor of EV in patients with HCV, independent of the comorbidity of diabetes or even metabolic syndrome.
In the case of variceal existence in the present study, we recorded higher HOMA-IR scores. This positive association remained existing within different variceal grades. Moreover, the high HOMA-IR score was an independent predictor for the presence of EV in our cohort.
Previous studies investigated the association of IR with portal hypertension or EV in different situations. A recent Japanese study examined 53 patients with heterogeneous kinds of chronic liver diseases and found a close link between IR and impaired portal hemodynamics (23) . The Japanese study did not exclude, however, patients who are obese or have diabetes. A similar finding was reported by a similarly designed Egyptian study (24) . Degré et al. (25) In contrast with the present study, 26% of their patients already had diabetes, and some were obese.
Previous studies, however, demonstrated the presence of IR before the occurrence of diabetes (3,11). These data are in accordance with our results in patients without diabetes or metabolic syndrome comorbidity. In addition, the underlying mechanism responsible for HCV-related IR (although beyond the scope of this article) is not po- tentially the same as that of the "regular" metabolic syndrome (27) . Furthermore, the use of insulin-sensitizing drugs, usually prescribed for that syndrome, remained a matter of controversy for the HCV-induced IR (28) .
The striking result in our setting is the validity of the ratio of insulin/HDL-C as a new independent predictor of variceal development. Despite the current evidence of a strong correlation between them and although not far from the concept of IR, this novel predictor is potentially more sensitive than the traditional HOMA-IR scoring (OR, 14.220, p=0.010 and OR, 1.303, p=0.039, respectively).
That is just what we have also confirmed from data of the ROC curve (the sensitivity of the cut-off values was 89% for insulin/HDL-C ratio versus 72% for HOMA-IR scoring).
Another advantage of this newly identified predictor is that it does not include blood glucose as an element in its component. Hence, it may be more credible in patients without diabetes or even impaired glucose homeostasis, particularly as a considerable category of patients with HCV remains unsuffered from diabetes.
Interestingly, on performing the multivariate analysis in the subgroup of patients previously treated with direct antiviral drugs, no independent predictors resulted. Therefore, it appears that the above predictors might lose their reliability with the improvement of insulin sensitivity already gained by the successful viral clearance (29) .
One of the limitations of the present study is the relatively limited sample size. In addition, the diagnosis of cirrhosis was based on the clinical and imaging criteria rather than the invasive liver biopsy. Finally, we did not test the HCV-RNA for all patients. Nevertheless, we have used the third generation ELISA-based diagnosis that detects all the HCV genotypes with an accuracy of 99% for both specificity and sensitivity (30) . The main strength of this work came from performing the study on a homogeneous population with compensated HCV-induced cirrhosis who were assessed by the same endoscopist.
Two independent predictors of EV in patients with child a HCV cirrhosis have been validated in the absence of diabetes or metabolic syndrome, HOMA-IR score and insulin/HDL-C ratio. The latter is a novel marker and is more sensitive. The predictors lose their validity if the patient is cleared of the virus using recent drugs. The identification of two predictors that are potentially related to IR in such population adds evidence to the previous data suggesting the underlying mechanism of HCV-related IR differs from that of type 2 diabetes and metabolic syndrome.
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